Company page

Adhera Therapeutics Inc.

Adhera Therapeutics Inc. is a public company traded under the ticker ATRX in the American market, with a market capitalization of approximately $722.09 million. The company focuses on developing innovative therapeutics to improve patient outcomes. Adhera is committed to advancing its pipeline of treatments to address significant medical needs.